drug development Archives | Be Korea-savvy

Home / Posts tagged drug development

Informa Pharma Intelligence Launches Preferred Partner Network to Provide Enhanced Specialist Support for Customers’ Content and Technology Needs

NEW YORK, Nov. 17 (Korea Bizwire) – Informa Pharma Intelligence, the global business intelligence provider for the biopharma industry, announced the launch of its Preferred Partner Network to enhance the services supplied to customers across the drug development lifecycle. Built on Informa Pharma’s deep industry expertise and years of collaborating with like-minded companies, the network will [...]

Patient-Derived Tumor Organoid Drug Development Platform Launched

SAN DIEGO, Oct. 17 (Korea Bizwire) — Crown Bioscience today announced the launch of a new tumor organoid drug development platform with the potential to significantly improve the predictivity and speed of preclinical drug discovery. The initial phase of the platform launch features the first commercially available 3D in vitro PDX-derived organoid (PDXO) models generated from CrownBio’s [...]

IHMA Announces a New Venture in India to Further Their Global Support of Anti-infective Drug Development for the Biopharmaceutical Industry

SCHAUMBURG, Ill., Oct. 31 (Korea Bizwire) — International Health Management Associates, Inc./IHMA Europe Sàrl (IHMA), a global company that provides laboratory and consultative services to the biopharmaceutical industry involved in the development of products for the prevention, control and treatment of infectious diseases has announced the establishment of an affiliate in India (IHMA India, LLP). [...]

S. Korea to Use AI in Drug Discovery

SEOUL, Jun. 7 (Korea Bizwire) — South Korea will spearhead a project to develop a drug platform based on artificial intelligence (AI) and big data, the government said Thursday, in the latest effort to transform the country into a global biotech and medical industry hub. A total of four research centers and universities — the [...]

IHMA Completes the Globalization of its Two Laboratories with the Recent College of American Pathologists (CAP) Accreditation of IHMA Europe, Enhancing Support for Clinical Trials in Anti-Infective Drug Development and Global Surveillance Studies

SCHAUMBURG, Ill., Mar. 6 (Korea Bizwire) — On 14th October 2017 IHMA Europe Sàrl, located in Monthey, Valais, Switzerland, was awarded accreditation by the College of American Pathologists (CAP). With this important development both IHMA facilities, located in the US and Europe, are now CAP accredited. These accreditations further advance IHMA’s global commitment to the [...]